Latest CSL News

First approved treatment for people living with moderate-to-severe itch (pruritus) associated with chronic kidney disease added to the PBS
AECOM appoints Heidi Sick to lead its energy and environment team in Australia and New Zealand
UniSC helping to determine next flu vaccine for Southern Hemisphere
Cell & Gene Catalyst submits feedback on HTA consultation
Australian Institute for Infectious Disease (AIID) announces early works contractor
Jobs Boost As World-Leading Company Makes Parkville Home
Targeting inflammatory protein could help treat severe asthma
Intravenous iron treatment Ferinject® (ferric carboxymaltose) now approved for Australian children aged one to thirteen years living with iron deficiency anaemia
CSL reports strong first half growth with immunoglobulins the highlight
Cell & Gene Catalyst working groups members announced
Year of collective success: 2023 in review
AusBiotech energised by new Board appointments
Australia’s Cell and Gene Catalyst calls for Expressions of Interest
Victorian manufacturing industry on show
New survey shows significant gaps in Australians understanding of Iron Deficiency
Successful clinical trial for re-engineered UQ vaccine
Victoria’s Consular Corps visit Monash, scientists showcase latest innovations
AusBiotech Board election result announced
We could see thunderstorm asthma in south-eastern Australia this season – here’s how to prepare
Australia’s most sustainable tapware company wins big at local awards
New approaches to blood and liver cancer therapies recognised with $2.5 million CSL Centenary Fellowships
CSL announces seven new Global Research Acceleration Initiative projects
Director appointed to Australia’s Cell and Gene Catalyst
Novel therapeutics development highlighted in Australasian Biotechnology journal
Save $350 with AusBiotech 2023 early-bird rates
AusBiotech 2023 programme launched
CSL reports strong profit growth with record plasma collections
AusBiotech 2023 Millis Orator announced
New precision identifies microbiome keys to IBD
ACDC funding to power up coronary artery disease research
The new ‘Jumar Bioincubator’ calls for biotechnology start-ups
TGA approves pathway for more plasma donors
Lifeblood sexual activity and PrEP deferrals
Expert comment: will Twitter’s appointment of a female CEO pave the way for females in big tech?
Target for imaging could improve detection of blood clots
Resistance-fighting antimalarial drug candidate enters the clinic
Prestigious Snow Medical Fellowship for Dr Michelle Boyle
Devonport collision highlights importance of bridge resource management
Starpharma announces appointment of chief financial officer
Australian Cell and Gene Catalyst takes step forward
CSL reports positive results from pivotal late-stage trial of first-in-class garadacimab
Houstonians’ input on study for trauma patient who are ‘bleeding out’
Europe approves CSL’s first gene therapy for Haemophilia B
Key franchise delivers for CSL as plasma collections top pre-pandemic levels
WA Government collaboration with Brandon BioCatalyst set to continue
Positive CHMP Opinion Etranacogene Dezaparvovec
CSL announces appointment of its new CEO and managing director
CSL Announces Next CEO & Managing Director